Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of three compounds (viability/apoptosis dataset 2 of 2) - Dataset (ID:20273)

Filter results: >>>>
Cell Small Molecule 1 Small Molecule 2 Small Molecule 3 Small Mol 1 Concentration Small Mol 2 Concentration Small Mol 3 Concentration Small Mol Conc Unit Time Point Time Point Unit Replicate Total Number of Cells (Nuclei) Number of Apoptotic Cells Relative Viability Mean Relative Viability Apoptosis Fraction Mean Apoptosis Fraction
MMAC-SF Vemurafenib Trametinib JNK-IN-8 3.1600 0.3160 1.0000
uM
72
hr
2 408 124 0.2812 0.2710 0.3039 0.3368
MMAC-SF Vemurafenib Trametinib JNK-IN-8 3.1600 0.3160 1.0000
uM
72
hr
3 272 104 0.1663 0.2710 0.3824 0.3368
MMAC-SF Vemurafenib Trametinib JNK-IN-8 3.1600 0.3160 3.1600
uM
72
hr
1 396 101 0.2921 0.2729 0.2551 0.2392
MMAC-SF Vemurafenib Trametinib JNK-IN-8 3.1600 0.3160 3.1600
uM
72
hr
2 365 92 0.2703 0.2729 0.2521 0.2392
MMAC-SF Vemurafenib Trametinib JNK-IN-8 3.1600 0.3160 3.1600
uM
72
hr
3 328 69 0.2564 0.2729 0.2104 0.2392
MMAC-SF Vemurafenib Trametinib PF562271 0.0000 0.0000 0.0000
uM
72
hr
1 1157 57 0.9510 1.0000 0.0493 0.0504
MMAC-SF Vemurafenib Trametinib PF562271 0.0000 0.0000 0.0000
uM
72
hr
2 1187 63 0.9718 1.0000 0.0531 0.0504
MMAC-SF Vemurafenib Trametinib PF562271 0.0000 0.0000 0.0000
uM
72
hr
3 1310 64 1.0772 1.0000 0.0489 0.0504
MMAC-SF Vemurafenib Trametinib PF562271 0.0000 0.0000 0.3160
uM
72
hr
1 1192 39 0.9968 1.2637 0.0327 0.0426
MMAC-SF Vemurafenib Trametinib PF562271 0.0000 0.0000 0.3160
uM
72
hr
2 1712 76 1.4144 1.2637 0.0444 0.0426
MMAC-SF Vemurafenib Trametinib PF562271 0.0000 0.0000 0.3160
uM
72
hr
3 1681 85 1.3798 1.2637 0.0506 0.0426
MMAC-SF Vemurafenib Trametinib PF562271 0.0000 0.0000 1.0000
uM
72
hr
1 794 27 0.6631 0.6202 0.0340 0.0473
MMAC-SF Vemurafenib Trametinib PF562271 0.0000 0.0000 1.0000
uM
72
hr
2 859 40 0.7081 0.6202 0.0466 0.0473
MMAC-SF Vemurafenib Trametinib PF562271 0.0000 0.0000 1.0000
uM
72
hr
3 603 37 0.4893 0.6202 0.0614 0.0473
MMAC-SF Vemurafenib Trametinib PF562271 0.0000 0.0000 3.1600
uM
72
hr
1 751 26 0.6268 0.4801 0.0346 0.0405
MMAC-SF Vemurafenib Trametinib PF562271 0.0000 0.0000 3.1600
uM
72
hr
2 577 29 0.4738 0.4801 0.0503 0.0405
MMAC-SF Vemurafenib Trametinib PF562271 0.0000 0.0000 3.1600
uM
72
hr
3 408 15 0.3398 0.4801 0.0368 0.0405
MMAC-SF Vemurafenib Trametinib PF562271 0.1000 0.0100 0.0000
uM
72
hr
1 516 186 0.2853 0.3170 0.3605 0.3752
MMAC-SF Vemurafenib Trametinib PF562271 0.1000 0.0100 0.0000
uM
72
hr
2 642 246 0.3424 0.3170 0.3832 0.3752
MMAC-SF Vemurafenib Trametinib PF562271 0.1000 0.0100 0.0000
uM
72
hr
3 605 231 0.3233 0.3170 0.3818 0.3752
MMAC-SF Vemurafenib Trametinib PF562271 0.1000 0.0100 0.3160
uM
72
hr
1 609 230 0.3277 0.3533 0.3777 0.3907
MMAC-SF Vemurafenib Trametinib PF562271 0.1000 0.0100 0.3160
uM
72
hr
2 683 242 0.3813 0.3533 0.3543 0.3907
MMAC-SF Vemurafenib Trametinib PF562271 0.1000 0.0100 0.3160
uM
72
hr
3 725 319 0.3510 0.3533 0.4400 0.3907
MMAC-SF Vemurafenib Trametinib PF562271 0.1000 0.0100 1.0000
uM
72
hr
1 456 187 0.2326 0.1795 0.4101 0.4353
MMAC-SF Vemurafenib Trametinib PF562271 0.1000 0.0100 1.0000
uM
72
hr
2 347 151 0.1695 0.1795 0.4352 0.4353